The Supreme Court of Appeals upheld the ruling of the lower courts, which deprived the driver of his driving rights for 1.5 years after a medical examination revealed the presence of pyrovalerone. This substance appears in some drugs aimed at reducing apathy or aiding weight loss. The case underscores how drug tests can impact a person’s ability to operate a vehicle, even when other indicators are inconclusive.
District traffic officers initially suspected intoxication due to the driver’s unusual skin tone, but a field check did not show alcohol in the breath. A subsequent examination at a medical facility detected pyrovalerone in the driver’s system, a substance listed among narcotic and psychotropic compounds and their precursors. This finding played a decisive role in the authorities’ assessment of impairment related to driving ability.
The Supreme Court noted that the relevant regulatory framework prohibits driving under the influence of substances that can impair reaction time and attention. The rider’s complaint about the decision was found to be unfounded within that framework, reinforcing the earlier court’s decision to suspend driving privileges for the specified period.
Earlier reports indicated a separate incident in Krasnoyarsk involving a vehicle connected to a drunk individual who allegedly collapsed near a private residence. The events surrounding that episode contributed to ongoing discussions about road safety and the enforcement of drug- and alcohol-related driving penalties in the region.